Nexalin Technology (NXL) Competitors $0.95 +0.01 (+1.50%) Closing price 04:00 PM EasternExtended Trading$0.96 +0.01 (+0.53%) As of 06:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NXL vs. TELA, MDAI, CTSO, SURG, DXR, PYPD, SRTS, GUTS, NMTC, and APTShould you be buying Nexalin Technology stock or one of its competitors? The main competitors of Nexalin Technology include TELA Bio (TELA), Spectral AI (MDAI), Cytosorbents (CTSO), SurgePays (SURG), Daxor (DXR), PolyPid (PYPD), Sensus Healthcare (SRTS), Fractyl Health (GUTS), NeuroOne Medical Technologies (NMTC), and Alpha Pro Tech (APT). These companies are all part of the "medical equipment" industry. Nexalin Technology vs. Its Competitors TELA Bio Spectral AI Cytosorbents SurgePays Daxor PolyPid Sensus Healthcare Fractyl Health NeuroOne Medical Technologies Alpha Pro Tech TELA Bio (NASDAQ:TELA) and Nexalin Technology (NASDAQ:NXL) are both small-cap medical equipment companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, earnings, institutional ownership, media sentiment, profitability, valuation and analyst recommendations. Do institutionals and insiders have more ownership in TELA or NXL? 94.4% of TELA Bio shares are owned by institutional investors. Comparatively, 0.7% of Nexalin Technology shares are owned by institutional investors. 4.7% of TELA Bio shares are owned by company insiders. Comparatively, 25.3% of Nexalin Technology shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Does the media refer more to TELA or NXL? In the previous week, Nexalin Technology had 1 more articles in the media than TELA Bio. MarketBeat recorded 3 mentions for Nexalin Technology and 2 mentions for TELA Bio. TELA Bio's average media sentiment score of 1.47 beat Nexalin Technology's score of 0.66 indicating that TELA Bio is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TELA Bio 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Nexalin Technology 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility & risk, TELA or NXL? TELA Bio has a beta of 0.84, indicating that its share price is 16% less volatile than the S&P 500. Comparatively, Nexalin Technology has a beta of 3.68, indicating that its share price is 268% more volatile than the S&P 500. Which has higher valuation and earnings, TELA or NXL? Nexalin Technology has lower revenue, but higher earnings than TELA Bio. TELA Bio is trading at a lower price-to-earnings ratio than Nexalin Technology, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTELA Bio$69.30M0.86-$37.84M-$1.12-1.34Nexalin Technology$170K98.63-$7.61M-$0.76-1.25 Is TELA or NXL more profitable? TELA Bio has a net margin of -54.12% compared to Nexalin Technology's net margin of -5,057.14%. Nexalin Technology's return on equity of -209.20% beat TELA Bio's return on equity.Company Net Margins Return on Equity Return on Assets TELA Bio-54.12% -329.48% -57.34% Nexalin Technology -5,057.14%-209.20%-186.87% Do analysts prefer TELA or NXL? TELA Bio currently has a consensus price target of $4.50, suggesting a potential upside of 200.00%. Nexalin Technology has a consensus price target of $5.00, suggesting a potential upside of 426.32%. Given Nexalin Technology's stronger consensus rating and higher possible upside, analysts clearly believe Nexalin Technology is more favorable than TELA Bio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TELA Bio 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Nexalin Technology 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryNexalin Technology beats TELA Bio on 9 of the 14 factors compared between the two stocks. Get Nexalin Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for NXL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NXL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NXL vs. The Competition Export to ExcelMetricNexalin TechnologyTechnology Services IndustryBusiness SectorNASDAQ ExchangeMarket Cap$16.52M$3.18B$27.56B$10.42BDividend YieldN/A1.61%2.77%4.69%P/E RatioN/A24.5326.5726.39Price / Sales98.6351.70772.45125.20Price / CashN/A44.1226.7230.68Price / Book3.397.777.996.40Net Income-$7.61M$35.34M$199.92M$276.69M7 Day Performance-1.04%-3.91%-1.79%-0.28%1 Month Performance-0.66%13.31%10.60%6.69%1 Year Performance34.56%43.34%49.17%27.61% Nexalin Technology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NXLNexalin Technology1.9075 of 5 stars$0.95+1.5%$5.00+426.3%+32.6%$16.52M$170K0.003TELATELA Bio2.8286 of 5 stars$1.64+1.9%$4.50+174.4%-44.9%$64.98M$69.30M-1.46120MDAISpectral AI2.8206 of 5 stars$2.42+2.8%$3.50+44.9%+73.6%$64.55M$29.58M-3.5083Gap UpCTSOCytosorbents2.0765 of 5 stars$0.97+0.4%$5.50+467.0%-37.8%$61.19M$35.60M-5.74220SURGSurgePays3.1954 of 5 stars$2.98+0.3%$9.00+202.0%+56.6%$60.82M$60.88M-1.2040DXRDaxor3.8529 of 5 stars$11.67-0.8%$25.00+114.2%+35.5%$56.48MN/A0.0037Gap UpPYPDPolyPid3.259 of 5 stars$3.51-1.1%$12.40+253.2%-7.7%$55.90MN/A-0.9280Analyst UpgradeSRTSSensus Healthcare2.5996 of 5 stars$3.22+2.1%$8.00+148.8%-47.3%$52.86M$41.81M-53.5840Positive NewsGap UpGUTSFractyl Health2.4588 of 5 stars$1.02+2.3%$7.15+604.4%-47.7%$51.04M$90K-0.49102Analyst ForecastGap UpNMTCNeuroOne Medical Technologies3.0535 of 5 stars$1.02+9.0%$2.23+119.2%-9.9%$50.75M$3.45M-6.7720Positive NewsGap UpAPTAlpha Pro Tech1.5298 of 5 stars$4.77-0.1%N/A-14.4%$49.90M$58.56M12.88120 Related Companies and Tools Related Companies TELA Bio Alternatives Spectral AI Alternatives Cytosorbents Alternatives SurgePays Alternatives Daxor Alternatives PolyPid Alternatives Sensus Healthcare Alternatives Fractyl Health Alternatives NeuroOne Medical Technologies Alternatives Alpha Pro Tech Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NXL) was last updated on 9/29/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | Sponsored2013 Bitcoin miner reveals his trading system (free)There are 18,347 cryptocurrencies in the market right now. 99% of them will fail. And trying to pick winner...Crypto Swap Profits | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nexalin Technology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nexalin Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
